FDA — authorised 3 September 2020
- Marketing authorisation holder: RADIOMEDIX
- Status: approved
🇺🇸 Detectnet in United States
FDA authorised Detectnet on 3 September 2020
Marketing authorisations
FDA — authorised 3 September 2020
- Application: NDA213227
- Marketing authorisation holder: CURIUM
- Local brand name: DETECTNET
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
Detectnet in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Detectnet approved in United States?
Yes. FDA authorised it on 3 September 2020; FDA authorised it on 3 September 2020.
Who is the marketing authorisation holder for Detectnet in United States?
RADIOMEDIX holds the US marketing authorisation.